Lundbeck to Buy Alder BioPharma in US$2 Billion Deal

Lundbeck will add Alder BioPharma's potential blockbuster migraine treatment, eptinezumab, to its pipeline ahead of patent expirations.

Puma Gets FDA Approval for Supplemental New Drug Application

The company said the FDA has confirmed the action date for review of the supplemental new drug application will be...

Millennial Esports’ Data Segment Reports Increase in Streaming

Esports streaming has received 746 million more viewing hours than it did the previous year, reports Stream Hatchet, a division...

Infinity Lithium Releases PFS for San José Lithium Hydroxide Project

The study estimates a net present value at a 10 percent discount of US$860 million and an internal rate of...

Potash Fertilizers: What’s the Difference Between SOP and MOP?

SOP and MOP are the most common potash fertilizers used by farmers to grow crops. Here's what makes them different...

Atalaya’s Proyecto Riotinto Expansion Hits Full Mechanical Completion

Atalaya Mining has announced the full mechanical completion of an expansion project at its Proyecto Riotinto copper asset in Spain.

Cannabis Companies Move to FSE to Access European Market

The growing European market is becoming an attractive space for cannabis companies as they move to the Frankfurt Stock Exchange.